AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT104.61-0.64 (-0.61%) ▼|ACN175.94+0.10 (+0.06%) ▲|ADBE250.87-4.00 (-1.57%) ▼|AMAT456.67-12.19 (-2.60%) ▼|AMD509.74-11.36 (-2.18%) ▼|AMGN390.18-1.09 (-0.28%) ▼|AMT174.98-0.60 (-0.34%) ▼|AMZN251.14-1.26 (-0.50%) ▼|AVGO359.25-5.13 (-1.41%) ▼|AXP321.15-0.65 (-0.20%) ▼|BA207.29+0.81 (+0.39%) ▲|BAC62.61-0.08 (-0.13%) ▼|BKNG173.65+0.22 (+0.13%) ▲|BLK1,067.32-5.20 (-0.48%) ▼|BMY64.39-0.02 (-0.03%) ▼|BNY162.60+0.03 (+0.02%) ▲|BRK-B507.32+0.56 (+0.11%) ▲|C138.00+0.19 (+0.14%) ▲|CAT809.00-7.05 (-0.86%) ▼|CL88.66+0.65 (+0.73%) ▲|CMCSA24.74+0.15 (+0.61%) ▲|COF209.00-1.95 (-0.92%) ▼|COP137.89+1.28 (+0.94%) ▲|COST910.45+7.85 (+0.87%) ▲|CRM244.22+0.02 (+0.01%) ▲|CSCO109.31-0.12 (-0.11%) ▼|CVS96.74+1.36 (+1.42%) ▲|CVX215.32+1.50 (+0.70%) ▲|DE676.67-0.62 (-0.09%) ▼|DHR200.69-4.30 (-2.10%) ▼|DIS104.09-0.09 (-0.08%) ▼|DUK120.79+0.35 (+0.29%) ▲|EMR148.07-2.33 (-1.55%) ▼|FDX308.33-0.90 (-0.29%) ▼|GD353.93+1.25 (+0.35%) ▲|GE323.99-1.45 (-0.45%) ▼|GEV937.18-13.43 (-1.41%) ▼|GILD145.60-0.06 (-0.04%) ▼|GM84.25+0.47 (+0.56%) ▲|GOOG327.17-1.21 (-0.37%) ▼|GOOGL329.11-1.54 (-0.47%) ▼|GS1,020.92-8.44 (-0.82%) ▼|HD306.26-4.23 (-1.36%) ▼|HON202.20-2.74 (-1.33%) ▼|IBM236.52-3.45 (-1.44%) ▼|INTC101.21-5.03 (-4.73%) ▼|INTU311.27-2.67 (-0.85%) ▼|ISRG349.01-4.23 (-1.20%) ▼|JNJ269.88+2.69 (+1.00%) ▲|JPM353.34-1.35 (-0.38%) ▼|KO88.65+1.07 (+1.22%) ▲|LIN466.67+0.02 (+0.00%) ▲|LLY1,130.15+5.89 (+0.52%) ▲|LMT526.16+1.67 (+0.32%) ▲|LOW196.14-2.47 (-1.24%) ▼|LRCX303.62-12.22 (-3.87%) ▼|MA564.85-2.77 (-0.49%) ▼|MCD254.89+1.35 (+0.53%) ▲|MDLZ62.39-0.04 (-0.06%) ▼|MDT91.36-0.55 (-0.60%) ▼|META653.24-0.45 (-0.07%) ▼|MMM162.71-1.71 (-1.04%) ▼|MO68.81+0.90 (+1.32%) ▲|MRK147.25-0.34 (-0.23%) ▼|MS214.48-0.87 (-0.40%) ▼|MSFT488.14-3.51 (-0.71%) ▼|MU987.89-39.88 (-3.88%) ▼|NEE83.02+0.35 (+0.42%) ▲|NFLX75.10-0.93 (-1.22%) ▼|NKE36.97-0.39 (-1.03%) ▼|NOW131.90+0.79 (+0.60%) ▲|NVDA219.19-4.48 (-2.00%) ▼|ORCL157.72-4.00 (-2.48%) ▼|PEP136.87+0.18 (+0.13%) ▲|PFE27.68-0.11 (-0.38%) ▼|PG143.04+0.37 (+0.26%) ▲|PLTR165.81-3.72 (-2.19%) ▼|PM189.72+4.03 (+2.17%) ▲|QCOM171.81-4.59 (-2.60%) ▼|RTX197.28-0.30 (-0.15%) ▼|SBUX99.90-0.14 (-0.14%) ▼|SCHW107.02+0.48 (+0.45%) ▲|SO88.63+0.28 (+0.32%) ▲|SPG206.05+1.42 (+0.69%) ▲|T25.65+0.49 (+1.95%) ▲|TMO599.60-6.57 (-1.08%) ▼|TMUS178.45+1.11 (+0.63%) ▲|TSLA361.49-6.33 (-1.72%) ▼|TXN257.18-4.41 (-1.69%) ▼|UBER69.68-1.43 (-2.00%) ▼|UNH398.24+5.17 (+1.31%) ▲|UNP287.53+2.74 (+0.96%) ▲|UPS99.38+0.16 (+0.16%) ▲|USB62.24+0.11 (+0.17%) ▲|V366.64-0.94 (-0.26%) ▼|VZ50.51+0.75 (+1.51%) ▲|WFC89.75+0.07 (+0.07%) ▲|WMT107.00+1.17 (+1.10%) ▲|XOM164.83+0.57 (+0.34%) ▲|AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT104.61-0.64 (-0.61%) ▼|ACN175.94+0.10 (+0.06%) ▲|ADBE250.87-4.00 (-1.57%) ▼|AMAT456.67-12.19 (-2.60%) ▼|AMD509.74-11.36 (-2.18%) ▼|AMGN390.18-1.09 (-0.28%) ▼|AMT174.98-0.60 (-0.34%) ▼|AMZN251.14-1.26 (-0.50%) ▼|AVGO359.25-5.13 (-1.41%) ▼|AXP321.15-0.65 (-0.20%) ▼|BA207.29+0.81 (+0.39%) ▲|BAC62.61-0.08 (-0.13%) ▼|BKNG173.65+0.22 (+0.13%) ▲|BLK1,067.32-5.20 (-0.48%) ▼|BMY64.39-0.02 (-0.03%) ▼|BNY162.60+0.03 (+0.02%) ▲|BRK-B507.32+0.56 (+0.11%) ▲|C138.00+0.19 (+0.14%) ▲|CAT809.00-7.05 (-0.86%) ▼|CL88.66+0.65 (+0.73%) ▲|CMCSA24.74+0.15 (+0.61%) ▲|COF209.00-1.95 (-0.92%) ▼|COP137.89+1.28 (+0.94%) ▲|COST910.45+7.85 (+0.87%) ▲|CRM244.22+0.02 (+0.01%) ▲|CSCO109.31-0.12 (-0.11%) ▼|CVS96.74+1.36 (+1.42%) ▲|CVX215.32+1.50 (+0.70%) ▲|DE676.67-0.62 (-0.09%) ▼|DHR200.69-4.30 (-2.10%) ▼|DIS104.09-0.09 (-0.08%) ▼|DUK120.79+0.35 (+0.29%) ▲|EMR148.07-2.33 (-1.55%) ▼|FDX308.33-0.90 (-0.29%) ▼|GD353.93+1.25 (+0.35%) ▲|GE323.99-1.45 (-0.45%) ▼|GEV937.18-13.43 (-1.41%) ▼|GILD145.60-0.06 (-0.04%) ▼|GM84.25+0.47 (+0.56%) ▲|GOOG327.17-1.21 (-0.37%) ▼|GOOGL329.11-1.54 (-0.47%) ▼|GS1,020.92-8.44 (-0.82%) ▼|HD306.26-4.23 (-1.36%) ▼|HON202.20-2.74 (-1.33%) ▼|IBM236.52-3.45 (-1.44%) ▼|INTC101.21-5.03 (-4.73%) ▼|INTU311.27-2.67 (-0.85%) ▼|ISRG349.01-4.23 (-1.20%) ▼|JNJ269.88+2.69 (+1.00%) ▲|JPM353.34-1.35 (-0.38%) ▼|KO88.65+1.07 (+1.22%) ▲|LIN466.67+0.02 (+0.00%) ▲|LLY1,130.15+5.89 (+0.52%) ▲|LMT526.16+1.67 (+0.32%) ▲|LOW196.14-2.47 (-1.24%) ▼|LRCX303.62-12.22 (-3.87%) ▼|MA564.85-2.77 (-0.49%) ▼|MCD254.89+1.35 (+0.53%) ▲|MDLZ62.39-0.04 (-0.06%) ▼|MDT91.36-0.55 (-0.60%) ▼|META653.24-0.45 (-0.07%) ▼|MMM162.71-1.71 (-1.04%) ▼|MO68.81+0.90 (+1.32%) ▲|MRK147.25-0.34 (-0.23%) ▼|MS214.48-0.87 (-0.40%) ▼|MSFT488.14-3.51 (-0.71%) ▼|MU987.89-39.88 (-3.88%) ▼|NEE83.02+0.35 (+0.42%) ▲|NFLX75.10-0.93 (-1.22%) ▼|NKE36.97-0.39 (-1.03%) ▼|NOW131.90+0.79 (+0.60%) ▲|NVDA219.19-4.48 (-2.00%) ▼|ORCL157.72-4.00 (-2.48%) ▼|PEP136.87+0.18 (+0.13%) ▲|PFE27.68-0.11 (-0.38%) ▼|PG143.04+0.37 (+0.26%) ▲|PLTR165.81-3.72 (-2.19%) ▼|PM189.72+4.03 (+2.17%) ▲|QCOM171.81-4.59 (-2.60%) ▼|RTX197.28-0.30 (-0.15%) ▼|SBUX99.90-0.14 (-0.14%) ▼|SCHW107.02+0.48 (+0.45%) ▲|SO88.63+0.28 (+0.32%) ▲|SPG206.05+1.42 (+0.69%) ▲|T25.65+0.49 (+1.95%) ▲|TMO599.60-6.57 (-1.08%) ▼|TMUS178.45+1.11 (+0.63%) ▲|TSLA361.49-6.33 (-1.72%) ▼|TXN257.18-4.41 (-1.69%) ▼|UBER69.68-1.43 (-2.00%) ▼|UNH398.24+5.17 (+1.31%) ▲|UNP287.53+2.74 (+0.96%) ▲|UPS99.38+0.16 (+0.16%) ▲|USB62.24+0.11 (+0.17%) ▲|V366.64-0.94 (-0.26%) ▼|VZ50.51+0.75 (+1.51%) ▲|WFC89.75+0.07 (+0.07%) ▲|WMT107.00+1.17 (+1.10%) ▲|XOM164.83+0.57 (+0.34%) ▲|
22.8 C
New York
Thursday, September 10, 2026

Tag: performance

Sandstorm Gold Royalties Supports Royal Gold’s Acquisition of Kansanshi Gold Stream

VANCOUVER, BC, Aug. 5, 2025 /CNW/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) today acknowledges and...

Sandstorm Gold Royalties Supports Royal Gold’s Acquisition of Kansanshi Gold Stream

VANCOUVER, BC, Aug. 5, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) today acknowledges and...

CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them

Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells

Open Sky Group Joins SAP PartnerEdge Open Ecosystem to Strengthen Client Digital Transformation

RALEIGH, N.C., Aug. 5, 2025 /PRNewswire/ -- Open Sky Group is proud to announce its official acceptance into the SAP PartnerEdge Open Ecosystem. This...

Where Innovation Flows: Narwal to Showcase Visionary Deep Cleaning Tech at IFA 2025

BERLIN, Aug. 5, 2025 /PRNewswire/ -- Narwal, a global leader in intelligent floor care and one of the top five vacuum brands worldwide, is...

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive’s focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe.

Transaction in Own Shares

Transaction in Own Shares

International Petroleum Corporation Announces Second Quarter 2025 Financial and Operational Results and Releases Sustainability Report

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operational results and related management’s discussion and analysis (MD&A) for the three and six months ended June 30, 2025. IPC also released its sixth annual Sustainability Report detailing IPC’s sustainability approach and initiatives.

iValue Announces Strategic Partnership with Cyberbit to Strengthen Cybersecurity Readiness for Indian Enterprises

BENGALURU, India, Aug. 5, 2025 /PRNewswire/ -- iValue Group, a leading technology advisor for enterprise security and digital transformation, has announced a strategic partnership...

180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy

Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings Company plans to execute a differentiated yield generation...

Open Compute Project Enables Silicon Diversity in AI Clusters

Allows Performance Tuning Designs of AI Clusters to Specialized Workloads TAIPEI, Aug. 5, 2025 /PRNewswire/ -- Today, the Open Compute Project Foundation (OCP), the nonprofit...

Sciaticyl’s “Nerve Reset” Discovery Sparks 2025 Surge in Sciatica Support Solutions Across U.S.

A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.
A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPerformance